KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Share-based Compensation (2016 - 2025)

Elevance Health (ELV) has disclosed Share-based Compensation for 16 consecutive years, with $30.0 million as the latest value for Q4 2025.

  • Quarterly Share-based Compensation rose 203.45% to $30.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $276.0 million through Dec 2025, up 44.5% year-over-year, with the annual reading at $276.0 million for FY2025, 44.5% up from the prior year.
  • Share-based Compensation for Q4 2025 was $30.0 million at Elevance Health, down from $84.0 million in the prior quarter.
  • The five-year high for Share-based Compensation was $92.0 million in Q2 2024, with the low at -$29.0 million in Q4 2024.
  • Average Share-based Compensation over 5 years is $63.8 million, with a median of $69.0 million recorded in 2021.
  • The sharpest move saw Share-based Compensation plummeted 140.28% in 2024, then surged 203.45% in 2025.
  • Over 5 years, Share-based Compensation stood at $59.0 million in 2021, then grew by 23.73% to $73.0 million in 2022, then decreased by 1.37% to $72.0 million in 2023, then tumbled by 140.28% to -$29.0 million in 2024, then soared by 203.45% to $30.0 million in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $30.0 million, $84.0 million, and $81.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.